Checkpoint Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright downgraded Checkpoint Therapeutics (CKPT) to Neutral from Buy with a price target of $4.10, down from $20, following the ...
Indian Billionaire Dilip Shanghvi’s Sun Pharma To Buy U.S. Cancer Drug Maker For $355 Million
Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...
Fierce Pharma1d
On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. | Three ...
Sun Pharma to Acquire Checkpoint Therapeutics
(Nasdaq: CKPT) ("Checkpoint") today announced that they have entered into an agreement by which Sun Pharma will acquire ...
Traders Buy Large Volume of Call Options on Checkpoint Therapeutics (NASDAQ:CKPT)
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT – Get Free Report) was the target of some unusual options trading on Monday. Investors purchased 5,081 call options on the stock. This represents an increase ...
GlobalData on MSN1d
Sun Pharma agrees to acquire Checkpoint Therapeutics
Sun Pharmaceutical Industries has agreed to acquire Checkpoint Therapeutics, a company specialising in immunotherapy and ...
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Checkpoint Therapeutics, Inc. Buyout
Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities ...
CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale To Sun Pharma
On March 9, 2023, Checkpoint announced the deal with Sun Pharma, under which shareholders will receive $4.10 per share in cash (or a total of $355 million). if cosibelimab receives EU approval within ...